The Medical Device Business Journal — Medical Device News & Articles | MassDevice

BD (NYSE:BDX) announced today that it launched its next-generation glass prefillable syringe (PFS) for vaccine delivery.

Franklin Lakes, New Jersey-based BD’s new Effivax syringe features tightened specifications for processability, cosmetics, contamination and integrity. The company designed it in collaboration with top pharmaceutical firms to meet the evolving needs of vaccine manufacturing.

“As biopharmaceutical companies continue to rapidly grow their vaccine pipelines, demand for PFS is accelerating across the globe – given their proven ability to facilitate faster administration, support dose sparing and reduce vaccine waste,” said Eric Borin , worldwide president of BD Pharmaceutical Systems. “The launch of BD Effivax glass prefillable syringe strategically supports this growth and will create needed efficiencies in end-to-end production.”

Effivax glass PFS offers design enhancements focused on fill/finish and container reliability. The company designed it to reduce the risk of line stoppage. It also improves the total cost of ownership, manufacturing capacity and supply availability.

Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Business/Financial News, Drug-Device Combinations, News Well, Pharmaceutical Tagged With: BD

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.